Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Buy
58
MMS Quote, Financials, Valuation and Earnings
Last price:
$75.34
Seasonality move
:
3.26%
Day range:
$73.97 - $76.42
52-week range:
$63.77 - $93.97
Dividend yield:
1.59%
P/E ratio:
14.97x
P/S ratio:
0.84x
P/B ratio:
2.55x
Volume:
599K
Avg. volume:
518.3K
1-year change:
-9.98%
Market cap:
$4.2B
Revenue:
$5.3B
EPS (TTM):
$5.03
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Maximus has 36.75% upside to fair value with a price target of $103.00 per share.
MMS vs. S&P 500
-
Over the past 5 trading days, Maximus has overperformed the S&P 500 by 13.07% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Maximus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Maximus has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Maximus reported revenues of $1.4B.
Earnings Growth
-
Maximus has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Maximus reported earnings per share of $1.69.
Enterprise value:
5.6B
EV / Invested capital:
1.78x
Price / LTM sales:
0.84x
EV / EBIT:
11.39x
EV / Revenue:
1.04x
PEG ratio (5yr expected):
0.47x
EV / Free cash flow:
25.70x
Price / Operating cash flow:
20.62x
Enterprise value / EBITDA:
9.05x
Gross Profit (TTM):
$1.3B
Return On Assets:
7.34%
Net Income Margin (TTM):
5.56%
Return On Equity:
17.12%
Return On Invested Capital:
9.92%
Operating Margin:
11.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4.8B | $5.1B | $5.4B | $1.3B | $1.4B | |
| Gross Profit | $956.6M | $1.2B | $1.3B | $317.6M | $338.8M | |
| Operating Income | $295.3M | $392.5M | $493.3M | $127.5M | $153M | |
| EBITDA | $444M | $528.8M | $621.9M | $158.2M | $186.4M | |
| Diluted EPS | $2.81 | $3.81 | $5.03 | $1.31 | $1.69 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $932.1M | $1.1B | $951.9M | $1.1B | $1.3B | |
| Total Assets | $2.4B | $4.1B | $3.9B | $4B | $4.2B | |
| Current Liabilities | $593.7M | $753.3M | $681.2M | $728.7M | $721.2M | |
| Total Liabilities | $1.1B | $2.6B | $2.3B | $2.3B | $2.5B | |
| Total Equity | $1.4B | $1.6B | $1.6B | $1.8B | $1.7B | |
| Total Debt | $267.2M | $1.4B | $1.3B | $1.2B | $1.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $353M | $291.4M | $325.9M | $130.5M | $42.7M | |
| Cash From Investing | -$55.7M | -$118.8M | -$108.3M | -$42M | -$19.4M | |
| Cash From Financing | -$286.1M | -$173.6M | -$180.5M | -$122.9M | $8.9M | |
| Free Cash Flow | $286M | $186.9M | $219M | $105.2M | $25.5M | |
MMS
Sector
Market Cap
$4.2B
$596.4M
Price % of 52-Week High
80.15%
74.87%
Dividend Yield
1.59%
0%
Shareholder Yield
10.7%
2.39%
1-Year Price Total Return
-9.98%
-7.44%
Beta (5-Year)
0.615
0.781
Dividend yield:
1.59%
Annualized payout:
$1.20
Payout ratio:
23.75%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$68.89
200-day SMA
Sell
Level
$78.85
Bollinger Bands (100)
Buy
Level
66.48 - 74.72
Chaikin Money Flow
Buy
Level
52.3M
20-day SMA
Buy
Level
$68.30
Relative Strength Index (RSI14)
Buy
Level
72.14
ADX Line
Buy
Level
17.01
Williams %R
Sell
Level
-10.0733
50-day SMA
Buy
Level
$67.94
MACD (12, 26)
Buy
Level
0.85
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
60.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6957)
Buy
CA Score
(Annual)
Level (0.2818)
Buy
Beneish M-Score
(Annual)
Level (-2.7142)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.5225)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Stock Forecast FAQ
In the current month, MMS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MMS average analyst price target in the past 3 months is $103.00.
-
Where Will Maximus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Maximus share price will rise to $103.00 per share over the next 12 months.
-
What Do Analysts Say About Maximus?
Analysts are divided on their view about Maximus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Maximus is a Sell and believe this share price will drop from its current level to $90.00.
-
What Is Maximus's Price Target?
The price target for Maximus over the next 1-year time period is forecast to be $103.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MMS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Maximus is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MMS?
You can purchase shares of Maximus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Maximus shares.
-
What Is The Maximus Share Price Today?
Maximus was last trading at $75.34 per share. This represents the most recent stock quote for Maximus. Yesterday, Maximus closed at $75.32 per share.
-
How To Buy Maximus Stock Online?
In order to purchase Maximus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
